Eli Lilly CEO Dave Ricks Talks Fighting Obesity, Developing New Drugs

Eli Lilly CEO Dave Ricks Talks Fighting Obesi...

Up next

Charles Schwab Chief Fixed Income Strategist Kathy Jones Talks Treasuries and Fed Interest Rates

Kathy Jones, Chief Fixed Income Strategist at the Schwab Center for Financial Research, joins Scarlet Fu on "Bloomberg Real Yield." US Treasuries sank and bond traders increased their bets on a Federal Reserve interest-rate hike by October to 50% as concern mounts that a protract ...  Show more

President and CEO of Stew Leonard's, Steward Leonard Jr., Talks Consumer Spending and War Impact

President and CEO of Stew Leonard's, Steward Leonard Jr., joins "Bloomberg Intelligence" to talk about the impact of rising oil prices and the war in the Middle East on Stew Leonard's customers, as well as how Stew Leonard's is trying to help the consumer in the US economy.See om ...  Show more

Recommended Episodes

Bloomberg Surveillance: Bloomberg BNA's Eleanor Tyler on pharma
Bloomberg Surveillance

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  Show more

Eli Lilly: weight loss drugs and investing in the UK
Wake Up to Money

Sean Farrington speaks to Dave Ricks, chairman and chief executive of American pharmaceutical giant Eli Lilly. 

Obesity Drugs Enjoy a Much-Needed Winning Streak
Bloomberg Businessweek

Bloomberg Opinion Pharma Columnist Lisa Jarvis and Bloomberg News Health Reporter Madison Muller discuss a how a clinical trial in obesity drugs is punctuating a string of positive developments that could make the treatments more widely accessible. Kate Hao, Founder and CEO of Ha ...  Show more

Chicken-Finger Billionaire Unmasked; Health Care Woes
The Credit Edge by Bloomberg Intelligence

When fast-food chain Raising Cane’s tapped the US capital market this month, it revealed a $7.6 billion fortune held by CEO Todd Graves. Strong demand for the chicken-finger maker’s bonds highlights growing investor appetite for risky debt as the US economy appears headed for a s ...  Show more